Cargando…
Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
Chronic kidney disease (CKD) is well recognized as a distinct contributor to cardiac hypertrophy, while the underlying mechanism remains incompletely understood. Here, the authors show that myocardial mitochondrial oxidative damage is early and prominent in CKD and distinctively stimulates the STING...
Autores principales: | Han, Wenhao, Du, Changhong, Zhu, Yingguo, Ran, Li, Wang, Yue, Xiong, Jiachuan, Wu, Yiding, Lan, Qigang, Wang, Yaqin, Wang, Liting, Wang, Junping, Yang, Ke, Zhao, Jinghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436763/ https://www.ncbi.nlm.nih.gov/pubmed/36061341 http://dx.doi.org/10.1016/j.jacbts.2022.03.006 |
Ejemplares similares
-
DUSP2-mediated inhibition of tubular epithelial cell pyroptosis confers nephroprotection in acute kidney injury
por: Xiong, Jiachuan, et al.
Publicado: (2022) -
A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy
por: Shin, Borami, et al.
Publicado: (2019) -
Macrophage-Derived Exosomal Mir-155 Regulating Cardiomyocyte Pyroptosis and Hypertrophy in Uremic Cardiomyopathy
por: Wang, Bin, et al.
Publicado: (2020) -
Mitochondrial DNA in Uremia and New Targets to Treat Myocardial Hypertrophy in the Cardiorenal Syndrome
por: Bayliss, George
Publicado: (2022) -
Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)